Page last updated: 2024-10-22

theophylline and Carcinoma, Transitional Cell

theophylline has been researched along with Carcinoma, Transitional Cell in 1 studies

Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.

Research Excerpts

ExcerptRelevanceReference
"CYP1A2, CYP2D6 and N-acetyltransferase activities were estimated in 100 patients with bladder cancer and 84 control subjects from measurements of theophylline, metoprolol and isoniazid and their metabolites in urine, respectively."3.69CYP1A2 activity as a risk factor for bladder cancer. ( Jang, IJ; Kim, SW; Lee, KH; Lee, SH; Lee, SW; Oh, SJ; Shin, SG; Yim, DS, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, SW1
Jang, IJ1
Shin, SG1
Lee, KH1
Yim, DS1
Kim, SW1
Oh, SJ1
Lee, SH1

Other Studies

1 other study available for theophylline and Carcinoma, Transitional Cell

ArticleYear
CYP1A2 activity as a risk factor for bladder cancer.
    Journal of Korean medical science, 1994, Volume: 9, Issue:6

    Topics: Acetylation; Adult; Aged; Amines; Carcinoma, Transitional Cell; Case-Control Studies; Cytochrome P-4

1994